KR vs RNAZ · P/E 19, rev $147.12B vs $5.1M cap
Kroger Company (KR) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
Kroger Company (KR) is a grocery stores company listed on US.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
RNAZ does not have a complete income-statement cache yet.
KR currently screens at market cap $46.17B and trailing P/E 19.0. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the KR and RNAZ stock pages for the full models.
Not investment advice.